The text provides financial information for KLA Corporation, including its condensed consolidated balance sheets, statements of operations, comprehensive income, stockholders' equity, and cash flows for the six months ended December 31. It details the company's assets, liabilities, revenues, costs, expenses, net income, earnings per share, comprehensive income, and changes in stockholders' equity, giving a snapshot of KLA Corporation's financial standing and performance during the specified period. Additionally, the text discusses fair value and unrealized losses of securities, recent business combinations and dispositions with financial impacts, goodwill, purchased intangible assets, summary of debt with outstanding amounts and interest rates, impairment charges, and amortization expenses associated with assets.
The text provides an overview of a company, detailing its financial condition, results of operations, and management's outlook. The company is described as a leading supplier of process control and yield management solutions for the semiconductor and related electronics industries. It discusses forward-looking statements, risk factors impacting the business, financial details such as revenues and costs, segment performance, critical accounting estimates, impairment charges, tax provisions, cash flows, financing activities, credit ratings, liquidity, credit facility, off-balance sheet arrangements, and other financial considerations. The text emphasizes the company's ongoing commitment to R&D, capital expenditures, and strategic financial management guided by factors such as market trends and business performance.
The company discloses its market risks, including potential impacts on fixed income securities, fixed interest rate notes, and borrowing under a Revolving Credit Facility. These risks could result in declines in value, particularly due to interest rate changes. Additionally, market price risk affects equity investments, with a potential decline in value. The company also uses derivative instruments for managing foreign currency exchange risks, with hedging activities in place to mitigate these exposures. The company believes these strategies should have a minimal impact on its financial results or cash flows. Additional details and risks regarding these investments and activities are available in the company's financial statements and risk factor disclosures.
The text discusses the evaluation of disclosure controls and procedures by a company's CEO and CFO under the Securities Exchange Act of 1934. It states that the disclosure controls were effective at a reasonable assurance level at the end of the period covered by the report. It explains the definition of disclosure controls, their limitations on preventing errors and fraud, and the incorporation of internal controls over financial reporting. Additionally, it mentions that there were no changes in the internal control over financial reporting during the most recent fiscal quarter.
The text provided discusses how information related to litigation and other legal matters in the Condensed Consolidated Financial Statements has been referenced for further context.
The text explores numerous risks and challenges faced by a technology company, particularly in the semiconductor sector. These risks include vulnerabilities to changes in financial markets and the global economy, cybersecurity incidents, disruptions in manufacturing facilities or supply chains, and challenges related to international operations and regulations. Additionally, the company faces industry-specific risks, threats to its business model and capital structure, and risks related to government regulations and export controls, especially in China. Efforts to manage these risks, such as insurance coverage and cost-cutting measures, have been mentioned in the text, but there are certain risks that remain uninsurable or challenging to mitigate. Failure to address these risks adequately could significantly harm the company's operations, financial standing, and reputation.
The text provides a summary of stock repurchases that were made during the fourth quarter of 2023. The company repurchased a total of 848,349 shares during this period, with specific details broken down by month. The Board of Directors authorized a stock repurchase program, with approximately $3.02 billion remaining available for repurchases as of December 31, 2023. The program has no expiration date and may be suspended at any time, with potential for future repurchases through various transaction structures. The average price paid per share and the approximate dollar value of shares remaining available for repurchase do not include certain applicable fees or costs.
There are no defaults on senior securities mentioned in the text provided.
The text provided states that there are no mine safety disclosures applicable.
During the second quarter, officers of the company adopted trading plans to sell and/or gift shares of common stock issued upon vesting of RSUs or purchased in the Employee Stock Purchase Plan as per Rule 10b5-1(c) under the Exchange Act. Officers include Executive Vice President Oreste Donzella with a plan duration of 366 days and a maximum of 8,165 shares to be sold. President and CEO Richard Wallace also adopted a plan with a duration of 355 days and a maximum of 76,672 shares to be sold, subject to pricing conditions where the actual shares sold may be less. Each plan terminates once the last trade is placed, with specific termination dates based on their last scheduled trades.
The text pertains to various exhibits incorporated by reference, including the restated certificate of incorporation, amended and restated by-laws, KLA Corporation 2023 Incentive Award Plan, and related certifications. It also includes details on the XBRL Instance Document, Taxonomy Extension Schema Document, and other related files. Lastly, the signatures of the individuals certifying the report on behalf of KLA Corporation are provided, including the President, Chief Financial Officer, and Chief Accounting Officer, along with their respective titles and dates signed.
